B. Braun SE Overview
Company Headquarters: Melsungen, Germany
Founded: 1839
Workforce: ~ 66,234
Company Working: B. Braun SE (B. Braun) is a manufacturer and supplier of healthcare products for hospitals, surgical units, private practices (medical care and doctors’ offices), and extracorporeal blood treatments. Its key business areas include clinical nutrition, urinary care, infection prevention, infusion therapy, diabetes care, neurosurgery, extracorporeal blood treatment, IV drugs, orthopedics, spine, and wound care, among others. The company operates through four major business segments, namely, hospital care, Aesculap, outpatient market, and B. Braun Avitum. With these four divisions, the company offers over 5,000 products, out of which it manufactures 95% of the products. Geographically it operates in 64 countries across Europe, Asia-Pacific, Latin America, and the Middle East and Africa. It operates through various subsidiaries such as B. Braun Medical Inc., Aesculap AG, and B. Braun Avitum France SAS, among others.
Strategy
B. Braun SE is focused on expanding its product portfolio and increasing investment in research & development. It also focuses on expanding geographically through partnerships with its customers to understand their needs and develop appropriate and innovative solutions.
